|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
06990 SKB BIO-B
Nominal 
163.400 -3.700 (-2.214%) Profitability Analysis
| 2023/12 | 2022/12 | 2021/12 | |
| ROAA (%) | -25.501% | -68.224% | -109.452% |
| ROAE (%) | N/A | N/A | 33.655% |
| Return on Capital Employed (%) | -23.925% | N/A | N/A |
Margin Analysis
| 2023/12 | 2022/12 | 2021/12 | |
| Gross Profit Margin (%) | 49.282% | 65.566% | 36.498% |
| EBITDA Margin (%) | -22.947% | -43.860% | -2336.167% |
| Pre-tax Profit Margin (%) | -30.360% | -70.574% | -2752.908% |
| Net Profit Margin (%) | -37.269% | -76.636% | -2752.908% |
Liquidity Analysis
| 2023/12 | 2022/12 | 2021/12 | |
| Current Ratio (X) | 2.529 X | 0.080 X | 0.087 X |
| Quick Ratio (X) | 2.472 X | 0.067 X | 0.072 X |
Leverage Analysis
| 2023/12 | 2022/12 | 2021/12 | |
| Total Liabilities / Total Assets(%) | 33.628% | 424.845% | 425.218% |
| Total Debt / Total Assets (%) | 1.707% | 303.515% | 294.097% |
| Net Debt / Total Assets (%) | -41.851% | 294.155% | 284.035% |
| Total Debt / Shareholders' Funds (%) | 2.572% | N/A | N/A |
| Long Term Debt / Shareholders' Funds (%) | 0.237% | N/A | N/A |
| Net Debt / Shareholders' Funds (%) | -63.055% | N/A | N/A |
| Net Cash / (Debt) ($) | 1.469B | (2.921B) | (2.309B) |
| Net Cash / (Debt) per share ($) | 6.701 | -- | -- |
| Total Debt / Capital Employed (%) | 2.497% | N/A | N/A |
| Interest Coverage Ratio (X) | N/A | N/A | N/A |
Efficiency Analysis
| 2023/12 | 2022/12 | 2021/12 | |
| Inventory Turnover (Day) | 27.018 Day | 68.141 Day | 902.035 Day |
| Receivables Turnover (Day) | N/A | N/A | 1.649 Day |
| Payables Turnover (Day) | 63.261 Day | 64.248 Day | 1490.422 Day |
| Remarks: | Real time quote last updated: 14/11/2024 15:01 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 310,226 |
| %Change | -- |
| EPS / (LPS) | RMB 1.410 |
| NBV Per Share (¥) | RMB 14.401 |